E2F2/5/8 Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
E2F2/5/8 Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-03-22
DOI
10.3389/fonc.2019.00161
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Diagnostic and Prognostic Biomarkers in ovarian cancer and the potential roles of cancer stem cells – An updated review
- (2018) Thingreila Muinao et al. EXPERIMENTAL CELL RESEARCH
- An E2F7-dependent transcriptional program modulates DNA damage repair and genomic stability
- (2018) Jone Mitxelena et al. NUCLEIC ACIDS RESEARCH
- Loss of E2F7 confers resistance to poly-ADP-ribose polymerase (PARP) inhibitors in BRCA2-deficient cells
- (2018) Kristen E Clements et al. NUCLEIC ACIDS RESEARCH
- Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer
- (2018) Yunhai Li et al. Oncology Letters
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Atypical E2Fs inhibit tumor angiogenesis
- (2017) B G M W Weijts et al. ONCOGENE
- E2F8 is a Potential Therapeutic Target for Hepatocellular Carcinoma
- (2017) Yi Lv et al. Journal of Cancer
- E2F1, a Novel Regulator of Metabolism
- (2017) Pierre-Damien Denechaud et al. Frontiers in Endocrinology
- E2F1: a promising regulator in ovarian carcinoma
- (2016) Lei Zhan et al. TUMOR BIOLOGY
- Ovarian cancer
- (2016) Ursula A. Matulonis et al. Nature Reviews Disease Primers
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Common variants at theCHEK2gene locus and risk of epithelial ovarian cancer
- (2015) Kate Lawrenson et al. CARCINOGENESIS
- E2F8 as a Novel Therapeutic Target for Lung Cancer
- (2015) Sin-Aye Park et al. JNCI-Journal of the National Cancer Institute
- E2f3 in tumor macrophages promotes lung metastasis
- (2015) P Trikha et al. ONCOGENE
- The Prognostic Role and Relationship between E2F1 and SV40 in Diffuse Large B-Cell Lymphoma of Egyptian Patients
- (2015) Rehab M. Samaka et al. Analytical Cellular Pathology
- E2F8 as a Novel Therapeutic Target for Lung Cancer
- (2015) Sin-Aye Park et al. JNCI-Journal of the National Cancer Institute
- Midkine and syndecan-1 levels correlate with the progression of malignant gastric cardiac adenocarcinoma
- (2014) XIU-FENG HU et al. Molecular Medicine Reports
- E2F transcription factors and digestive system malignancies: How much do we know?
- (2013) Athanasios Xanthoulis WORLD JOURNAL OF GASTROENTEROLOGY
- Curtailing Overexpression of E2F3 in Breast Cancer Using siRNA (E2F3)-Based Gene Silencing
- (2012) Karuppaiya Vimala et al. ARCHIVES OF MEDICAL RESEARCH
- A systematic comparison and evaluation of high density exon arrays and RNA-seq technology used to unravel the peripheral blood transcriptome of sickle cell disease
- (2012) Nalini Raghavachari et al. BMC Medical Genomics
- Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
- (2012) Balázs Győrffy et al. ENDOCRINE-RELATED CANCER
- E2F1 apoptosis counterattacked: evil strikes back
- (2012) Brigitte M. Pützer et al. TRENDS IN MOLECULAR MEDICINE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Recent progress in the diagnosis and treatment of ovarian cancer
- (2011) Danijela Jelovac et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer
- (2011) D Reimer et al. ONCOGENE
- E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer
- (2010) Narasimhan Kothandaraman et al. BMC CANCER
- Checks and balances: E2F—microRNA crosstalk in cancer control
- (2010) Stephan Emmrich et al. CELL CYCLE
- Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/Rb2
- (2010) Jing Hu et al. INTERNATIONAL JOURNAL OF CANCER
- Predicting Malignant Potential of Gastrointestinal Stromal Tumors: Role of p16 and E2F1 Expression
- (2010) Umit Seza Tetikkurt et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicatesZEB2in tumor progression and prognosis
- (2009) Kosuke Yoshihara et al. CANCER SCIENCE
- A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer
- (2008) T. Bonome et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started